1. Urinary glycosaminoglycans were recovered from the papain digest of polyanions precipitated sequentially by cetylpyridinium chloride and sodium acetatesaturated ethanol. Those from the early morning urine of 48 stone formers and 43 normal control subjects measured 11 and 16pg of uronic acid/ml of urine, respectively. 2. Preparative agarose gel electrophoresis of' the recovered glycosaminoglycans in barium acetate buffer (pH 5.8) yielded fractions containing purely chondroitin sulphate, co-polymeric chondroitin/dermatan sulphates and heparan sulphate. Identification was based on the susceptibility of the fractions to chondroitinase or nitrous acid treatment. Similar compositions of glycosaminoglycan classes were observed in samples from stone formers and normal control subjects. 3. The fractionated glycosaminoglycans were dissolved in urine ultrafiltrate to assay for nucleationpromoting and growth-inhibiting activities towards crystallization of urinary calcium oxalate. When compared at the same uronic acid concentration, both the urinary chondroitin sulphate isomers and heparan sulphates of stone formers demonstrated the capacity to enhance crystal nucleation from calcium oxalate endogenous in urine ultrafiltrates, whereas only urinary heparan sulphates of normal control subjects demonstrated this capacity. 4. Tissuederived reference chondroitin sulphate, dermatan sulphate and heparin, when similarly tested, showed negligible crystal nucleation-promoting activity. The tissuederived heparan sulphate was similar to the urinary heparan sulphates in showing marked crystal nucleation-promoting activity. 5. Crystal-growth inhibitory activity was evident in all urinary glycosaminoglycan fractions studied. In particular, urinary heparan sulphate of normal control subjects showed higher activity than that of stone formers or the chondroitin sulphate isomers of both stone formers and normal control subjects (P< 0.005).
INTRODUCTION
The evidence that glycosaminoglycans (GAGs) inhibit calcium oxalate crystal growth and aggregation is based largely on test systems involving seeded crystal growth [l-51 or mixed suspension, mixed product removal continuous crystallization [6, 71. In these systems, where inhibitory activity was observed, the test GAGs were invariably introduced as dissolved components. However, in test systems where the polyanions were present not only as dissolved components, but also as immobilized ones, an additional and apparently opposite effect of promoting crystal nucleation has been observed [8, 91. This suggests that the immobilized polyanions provide sites for heterogeneous nucleation. In support of this hypothesis is the observation that heparan sulphate (HS) is frequently, although not always, present in the matrix of renal stones [lo, 111. To study the growth-inhibiting and nucleation-promoting effects of the urinary GAGs on calcium oxalate crystallization, we have therefore adopted a test system [9] that involves freezing so that the GAGs in question can co-exist as solubilized and immobilized components. In this system the urine ultrafiltrate, devoid of crystal-active macromolecules, provides a suitable metastable environment of urinary micro-ions for the introduction of test GAGs to study their effects on the crystallization of calcium oxalate from ions endogenous in urine.
GAGs are polyanionic polysaccharides present in tissues as proteoglycans and those in the urine are considered to be metabolic turnover products of the tissue proteoglycans [12] . The GAGs tested in crystallization studies [ 1-71, mainly chondroitin sulphate (CS) isomers and heparin, are commercially prepared from the tissues of origin, whereas the GAGs excreted in urine consist mainly of CS and urinary GAG extracts [14] [15] [16] , size-fractionated urinary macromolecules [I 7-19] or uromucoids [ZO] . Little is yet known about the relative effects of the individual urinary GAG classes because of inadequate technical means to separate urinary GAGs on a preparatory scale. Commercially available tissue-derived CS isomers and heparin will continue to be used to represent the activities of the urinary CS and HS until the separation of the urinary GAG classes can be achieved on a preparatory scale.
In this paper, we report the separation of urinary GAGs into CS and HS by application of preparative agarose gel electrophoresis and an evaluation of the relative effect of the electrophoretically separated urinary GAGs from stone formers and normal control subjects on both the nucleation and the growth of crystals of calcium oxalate arising from ions endogenous in urine.
MATERIALS AND METHODS

GAGs
Sources of tissue GAGs were as follows: CS (chondroitin 4-sulphate; Sigma) from whale cartilage, dermatan sulphate (DS; Sigma) from pig skin, HS (Upjohn) from beef lung and heparin (Sigma) from porcine intestinal mucosa.
Enzymes
Chondroitinase AC (chondroitin AC lyase, EC 4.2.2.5; from Flavobacterium heparinunt), chondroitinase ABC (chondroitin ABC lyase, EC 4.2.2.4; from Proteus vulgaris) and papain (EC 3.4.22.2) were from Sigma.
Recovery of urinary GAGs
Urinary GAGs were isolated from samples of early morning urine collected from healthy control subjects (aged 22-54 years) as well as from stone formers (aged 22-56 years). All subjects were male Chinese and were on normal diets. The samples were transported at 4°C and were processed as soon as they reached the laboratory. Urinary polyanions were recovered by sequential precipitation, first as the cetylpyridinium salt and subsequently as the sodium salt as described in [9, 213. Acidic glycoproteins that co-precipitated with the GAGs were digested by papain at 65°C [21] and the GAGs were recovered from the digest by the sequential precipitation procedure. The hexuronic acid contents of the GAGs were estimated by the carbazole reaction of Bitter and Muir [22] . Urine samples of stone formers were treated separately from those of normal control subjects.
Electrophoresis
Analytical electrophoresis of the urinary GAGs was performed on cellulose acetate in 0.05mol/l barium acetate buffer, pH 5.8, with the use of the Microzone apparatus (Beckman). The membranes were stained with 0.2% Alcian Blue [23] .
Agarose gel (1%) electrophoresis of the urinary GAGs was performed in the barium buffer with the use of a preparative apparatus [24] . Fractions, collected at 30 min intervals, were monitored for GAGs by turbidimetry with cetylpyridinium chloride [21] . GAGs were recovered from the fractions by the sequential precipitation procedure [9] . CS/ DS and HS therein were identified by their respective susceptibilities to digestion by chondroitinase AC, chondroitinase ABC [25] and treatment with nitrous acid [26] .
Crystallization assay
The assay was performed [9, 271 on test GAGs dissolved in ultrafiltrates (pH 5.3, 1250 mosmol/kg) prepared at a nominal cut-off of lOkDa (YM-10 membranes; Amicon) from urine of normal control subjects. The assay was similarly performed on the corresponding whole urine and urine ultrafiltrate. Standard reference GAGs as well as urinary GAGs which had been electrophoretically separated into CS/DS and HS were applied as test GAGs. The population density and size of calcium oxalate crystals observed in the urine ultrafiltrate in the presence of the test GAG were expressed as ratios to that observed in the neat urine ultrafiltrate to minimize effects due to micro-ions in the ultrafiltrate and thus demonstrate the effects due to the test GAG: a value of > 1 indicates promotion and a value of < 1 indicates inhibition.
Statistical analysis
Mann-Whitney U-test.
All statistical analyses were performed using the
RESULTS
Urinary GAGs
As the GAGs excreted in any one urine sample were insufficient for the preparative fractionation and subsequent analyses intended, those from normal control subjects were treated as one pool and those from stone formers as another pool. The GAGs recovered from urine of normal control subjects ( n = 43) and stone formers ( n = 48) measured 16 p g of uronic acid/ml of urine and 11 p g of uronic acid/ml of urine, respectively. Analytical electrophoresis of these on cellulose acetate showed Alcian Blue-stainable materials in the mobility range of the standard GAGs. The exact identities of the GAGs will be confirmed when larger quantities of the separated GAG classes can be obtained at the preparative level.
Preparative electrophoresis of urinary GAGs
In the normal control subjects, the electrophoretic profile indicates a fast-moving major peak and a slow-moving minor peak (Fig. la) . The relative electrophoretic mobility of the GAGs contained in each of the preparative fractions were reproducible on cellulose acetate (Fig. l a insert) , that is, each fraction is unique in electrophoretic mobility. The material in fractions pooled as NCl not only showed mobility similar to the reference CS but was also completely digested away by chondroitinase AC (Fig. 2, top, a, lanes 3 and 4) , thus providing evidence for the occurrence of pure CS in those leading fractions. The susceptibility of fractions pooled as NC2 to chondroitinase AC and further to chondroitinase ABC suggested the occurrence of a mixture of CS and DS (Fig. 2 , top, a, lanes 5-7). These GAGs ranged in mobilities from that of the reference CS to that of the reference DS without a clear separation from each other as is observable in the reference materials. This suggests that CS and DS are co-polymeric, at least in some of the GAG chains. Similarly, the susceptibility of fractions pooled as NC3 in turn to chondroitinases AC and ABC suggested the occurrence of CS/DS (Fig. 2 , top, b, lanes 3-5); co-eluted with CS/DS was HS which was susceptible to nitrous acid treatment (Fig. 2, top, b , lanes 5 and 6). Fractions pooled as NC4 consist of HS only, as evidenced by the disappearance of the heparin-like band with nitrous acid treatment only (Fig. 2, top, c, lanes 3-6) . Thus, the urinary CS/DS, unlike the reference GAGs, are heterogeneous in electrophoretic mobility; they are sufficiently different in electrophoretic mobility from the urinary HS to be separable from the latter, except for overlaps in NC3.
The GAGs recovered from urine of stone formers showed a preparative electrophoretic profile similar to that of the normal control subjects (Fig. lb) . Fractions pooled as SF1 and SF2 were susceptible to chondroitinase AC digestion; in SF2, a trace amount resistant to chondroitinase AC was susceptible to chondroitinase ABC digestion (Fig. 2, a,  lanes 3-7) . SF3, like NC3, represents CS/DS coeluting with HS (Fig. 2, bottom, b, lanes 3-6) . Fractions pooled as SF4 were HS only (Fig. 2,  bottom, b, lanes 3-6) . As the relative electrophoretic mobilities of the fractions were reproducible on cellulose acetate (Fig.16, insert) , fractions are again unique in electrophoretic mobilities.
Crystallization study
Reference GAGs. Over the concentration range of 10+-103 pg of uronic acid/ml, reference CS, DS and heparin dissolved in the urine ultrafiltrate induced a basal level of calcium oxalate crystal nucleation that is only slightly higher than that observed in the urine ultrafiltrates [(O.ll k0.020) x lo5 crystals/ml (meanf SEM), n = 181 (Figs. 3a-3c ). In contrast, reference HS in the range of lO-'-lOpg of uronic acid/ml showed enhanced nucleation of calcium oxalate crystals (Fig. 3 4 . The effect exceeded that observed in the whole urine [( 1.38 k0.22) x lo5 crystals/ml (n= 18)] from which the ultrafiltrates were prepared, but was well within that observed in the retentates [(6.42+ 1.34) x lo5 crystals/ml] obtained as a result of the ultrafiltrate preparations.
Urinary GAGs. Fractions similar in electrophoretic mobility were pooled as shown in Fig. 1 to provide sufficient material for comparison of crystallization activities on the basis of similar uronic acid content.
In general, over a range of 1-5pg of uronic acid/ ml, nucleation-promoting activities due to the fractionated urinary GAGs increased with concentration [28] . In the normal control subjects, HS in pool NC4 showed markedly greater nucleationpromoting activity than CS and CS/DS contained respectively in pools NC1 and NC2, when compared at 2.5pg of uronic acid/ml (Fig. 44 . Urinary CS or CS/DS of the normal control subjects contributed little, if any, additional activity over that due to the ultrafiltrate alone. In contrast, CS and CS/DS contained respectively in pools SF1 and SF2 showed higher nucleation-promoting activity than HS in SF4 at the same concentration of uronic acid (Fig. 44 . Though urinary HS of stone formers did contribute to the observed activity, it was only about a third as active as the urinary HS of normal control subjects when compared at 2.5pg of uronic acid/ml. Thus of the two classes of urinary GAGs, both the CS isomers and HS of stone formers possess the capacity to enhance nucleation of crystals of calcium oxalate from ions endogenous in urine, whereas only HS of normal control subjects possesses this capacity.
Crystal growth-inhibitory activities were evident in all urinary GAG fractions studied (Fig. 46) . HS in pool NC4 showed marked growth-inhibitory activity not only over CS (in NC1) or CS/DS (in NC2) of normal control subjects but also over CS (in SFl), CS/DS (in SF2) or HS (in SF4) of stone formers (Fig. 4b) . It is apparent then that in the normal control subjects, the distinguishing growthinhibitory activity of urinary HS tends to balance out the nucleation-promoting activity of this GAG fraction. In contrast, stone formers demonstrated generally lower level of growth-inhibitory activities in the urinary GAGs alongside marked nucleationpromoting activities, especially in the urinary CS.
DISCUSSION
In the present study, the separation of urinary CS and HS by electrophoresis in barium acetate buffer was achieved at the preparative level with agarose gel as support. Barium appears to bind differentially to iduronate-and glucuronate-containing GAGs such that the electrophoretic mobilities decrease in the order of CS, DS, HS and heparin [29] . The separation was comparable with that observed on cellulose acetate (Figs. 1 and 2 ), which serves analytical purposes. With the use of agarose gel cast in a preparative apparatus [24] that allows electroelution from the gel and timed collection of the eluted fractions, recoveries of > 90% were presently achieved. Compared with earlier chromatographic and electrophoretic attempts at separation of the heterodisperse urinary CS and HS on the basis of native charge or size [13, 301, the present system is improved in separation and recovery. The lack of adequate separation techniques on a preparative scale has therefore hampered investigations on the influence of individual urinary GAG classes on calcium oxalate crystallization until the present report of preparative separation by agarose gel electrophoresis in barium buffer. This is the first report of the influence of HS on the crystallization of urinary calcium oxalate. Urinary HS, separated from urinary CS, was similar to the tissue-derived reference HS in promoting nucleation but inhibiting growth of crystals of urinary calcium oxalate. Tissue HS, studied at 1-1Opg of uronic acid/ml, was significantly higher in nucleation-promoting activity than heparin similarly treated over a wider concentration range of 10-3-103 p g of uronic acid/ml. Thus, despite structural similarities between heparin and HS [3 13, heparin which is not found in urine cannot serve as a model for the crystallization activity of urinary HS. Earlier crystallization studies [l-71 which used heparin as a reference GAG to reflect the behaviour of urinary HS should therefore be interpreted with caution until a comparison has been made with urinary HS in the test systems concerned. The urinary CS of normal control subjects was found to be similar to the tissue-derived reference CS in showing only basal nucleation-promoting activity. Unlike those of the normal control subjects, urinary CS of stone formers showed distinct nucleation-promoting activity that was comparable with that of the urinary HS. The GAGs of normal urine have been reported to be heterogeneous with respect to sulphation and molecular size [13]. These features have been found to influence crystallization [32] . Variations in the peptide content and length of the carbohydrate-peptide linkage region were also observed in urinary CS of normal subjects [33] . Whether or not the associated peptides play a part in influencing crystallization remains to be investigated. Though urinary HS has not been similarly studied, the xylose content and the high molecular masses reported of normal urinary HS [34] suggested that at least some populations were excreted in forms with intact carbohydrate-peptide linkage and covalently linked peptides, little affected by endoglycosidases. It is possible then that, besides certain unique structural features common to the GAG chains of commercial and urinary HS, the peptides that remain attached to the urinary form may also influence crystallization. The extent to which the individual urinary GAGs of stone formers differ in structure from those of normal control subjects is still not clear and is worthy of investigation now that nucleation-promoting and growthinhibiting activities are identified in specific populations of urinary GAGs.
The preparative electrophoretic profile provides an approximate estimate of the relative abundance of nucleation-promoting/growth-inhibiting subpopulations in the urinary GAG pools extracted. Within the normal control subjects, crystal-active HS, eluted as the minor peak in the electrophoretic profile, constituted 11% of the pool. Within the stone formers, crystal-active CS, represented in the major peak of the electrophoretic profile, constituted >96% of the pool; HS, also crystal-active, was present in trace quantities (~4 % of the pool) in the tail of the profile. Individual variation in excretion of any of these crystal-active species remains to be studied. It should be noted, however, that the proportions reported here were based on GAGs extracted from early morning urine to take advantage of the peak in GAG excretion in normal subjects [35] . The knowledge of whether or not the excretion of the crystal-active GAG subpopulations follows a rhythmic cycle is required to identify the sampling period appropriate for measurement of crystal-active GAG excretion.
The population density of crystals formed in the presence of the electrophoretically fractionated urinary GAGs reached as high as 40-50 times that in the ultrafiltrate in the cases of both normal control subjects and stone formers (Fig. 4a) . The level of enhancement so observed was higher than that due to a crude urinary polyanion extract from normal urine but lower than that of a similar extract from urine of stone formers [9]. Apart from variations in the concentrations of crystal-active GAGs, the difference between the fractions and the crude extract may be due to the crystal-active effects of glycoproteins co-isolated with GAGs in the polyanionic extract or the co-operative actions of both. Indeed, nephrocalcin [36] , Tamm-Horsfall glycoprotein [37] and a urinary form of osteopontin [38] are urinary glycoproteins identified as inhibitors of calcium oxalate growth and aggregation; the former two were found to be 'defective' in stone formers. At high concentrations, Tamm-Horsfall glycoprotein was also identified as a promoter of crystallization [20] and crystal aggregation Cl5-J. Our investigation into the difference in crystallization activity of individual urinary GAGs between stone formers and normal control subjects and similar studies of the urinary glycoproteins will provide insight as to how these macromolecules would behave in combination in the concentrated regions of the urinary tract.
